MT1 melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells

Molecular and Cellular Endocrinology

Volumn 192, Issue 1-2, 2002, Pages 147-156

  Yuan, Lin ^a   Collins, April R ^a   Dai, Jun ^a   Dubocovich, Margarita L ^b   Hill, Steven M ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Breast cancer; Estrogen receptor; Melatonin; Mt1 receptor

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MELATONIN; MELATONIN RECEPTOR; MESSENGER RNA; N [2 (1 NAPHTHYL)ETHYL]CYCLOBUTANECARBOXAMIDE; PANCREAS POLYPEPTIDE; RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; CELL RECEPTOR; CELL SURFACE RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; HORMONE ANTAGONIST; HYBRID PROTEIN; MUCIN; MUSCLE PROTEIN; N (2 (1 NAPHTHALENYL)ETHYL)CYCLOBUTANECARBOXAMIDE; N-(2-(1-NAPHTHALENYL)ETHYL)CYCLOBUTANECARBOXAMIDE; NAPHTHALENE DERIVATIVE; NEUROPEPTIDE; PANCREAS SPASMOLYTIC POLYPEPTIDE; PEPTIDE; RNA; TFF3 PROTEIN, RAT; TREFOIL FACTOR; TUMOR PROTEIN;

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA VECTOR; DRUG EFFECT; GENETIC TRANSFECTION; HORMONE ACTION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADENOCARCINOMA; BIOSYNTHESIS; BREAST TUMOR; CELL CULTURE; CELL DIVISION; CHEMISTRY; COMPARATIVE STUDY; DRUG ANTAGONISM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ADENOCARCINOMA; BREAST NEOPLASMS; CELL DIVISION; COMPARATIVE STUDY; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HORMONE ANTAGONISTS; HUMAN; MELATONIN; NAPHTHALENES; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PEPTIDES; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFECTION; TUMOR CELLS, CULTURED; ESTROGEN RECEPTOR ALPHA; HUMANS; MUCINS; MUSCLE PROTEINS; NEUROPEPTIDES; RECEPTORS, MELATONIN;

EID: 0037188823     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00029-1     Document Type: Article

References (38)

1. Association between steroid hormone receptor status and disease-free interval in breast cancer
2. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily
3. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily (additions and corrections)
4. Effect of melatonin on cancer: Studies on MCF-7 breast cancer cells in culture
5. Inhibitory effects of the pineal hormone melatonin and underfeeding during the promotional phase of 7, 12-dimethylbenzanthracene (DMBA)-induced mammary tumorigenesis
6. Pineal melatonin inhibition of tumor promotion in the NMU mammary model of carcinogenesis: Potential involvement of mechanism in vivo
7. Demonstration of partial characterization of 2-iodomelatonin binding sites in experimental mammary carcinoma
8. Dual signaling of human Mel1a melatonin receptors via Gi2, Gi3, and Gq/11 proteins
9. The trefoil peptide TFF1 inhibits the growth of the human gastric adenocarcinoma cell line AGS
10. Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat
11. Melatonin inhibition of MCF-7 human breast-cancer cells growth: Influence of cell proliferation rate
12. Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatonin
13. Melatonin inhibits DNA synthesis in MCF-7 human breast cancer cells in vitro
14. Melatonin mediates two distinct reponses in vascular smooth muscle
15. Melatonin receptor antagonists that differentiate between the human Mell and Mellb recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor
16. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythyms
17. Expression cloning of a high affinity melatonin receptor from Xenopus dermal melanophores
18. PNR-2/pS2 immunohistochemical staining in breast cancer: Correlation with prognostic factors and endocrine response
19. Effect of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture
20. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system
21. Effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells
22. Seqence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7
23. Melatonin decreases cell proliferation and transformation in a melatonin receptor-dependent manner
24. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic nucleus
25. The immunoneuroendocrine role of melatonin
26. Colony-stimulating activity and hematopoietic rescue from cancer chemotherapy compounds are induced by melatonin via endogenous interleukin 4
27. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells
28. Melatonin modulation of estrogen-regulated proteins, growth factors, and proto-oncogenes in human breast cancer
29. Antiproliferative action of melatonin on human prostate cancer LNCaP cells
30. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors
31. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses
32. Molecular characterization of a second melatonin receptor expressed in human retina and brain: The Mel1b melatonin receptor
33. Tight association of the human Mel(1a)-melatonin receptor and G(i): Precoupling and constitutive activity
34. A daily neural signal for luteinizing hormone release in the untreated ovariectomized rat: Changes in gonadotropin-releasing hormone content of the preoptic area and hypothalamus throughout the day
35. Structure and function of the pS2 gene and estrogen receptor in human breast cancer cells
36. Melatonin, a suppressor of spontaneous murine mammary tumors
37. Characterization and regulation of the ML1A melatonin receptor stably expressed in Chinese hamster ovary cells